Clinical Trial Update: Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders

View source ↗

Summary

The clinical trial update reports on salvage therapy with bendamustine and rituximab in patients with relapsed or refractory chronic lymphoproliferative disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorders

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Relapsed or Refractory Chronic Lymphoproliferative Disorders | Status: COMPLETED